{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T13:27:06Z","timestamp":1790774826391,"version":"4.1.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. of Cardiovasc. Trans. Res."],"published-print":{"date-parts":[[2009,9]]},"DOI":"10.1007\/s12265-009-9105-x","type":"journal-article","created":{"date-parts":[[2009,5,18]],"date-time":"2009-05-18T19:46:50Z","timestamp":1242676010000},"page":"240-244","source":"Crossref","is-referenced-by-count":11,"title":["Estrogen-Eluting Stents"],"prefix":"10.1007","volume":"2","author":[{"given":"Sung Kee","family":"Ryu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ehtisham","family":"Mahmud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sotirios","family":"Tsimikas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,5,19]]},"reference":[{"key":"9105_CR1","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1056\/NEJM199906103402306","volume":"340","author":"ME Mendelsohn","year":"1999","unstructured":"Mendelsohn, M. E., & Karas, R. H. (1999). The protective effects of estrogen on the cardiovascular system. New England Journal of Medicine, 340, 1801\u20131811.","journal-title":"New England Journal of Medicine"},{"key":"9105_CR2","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1056\/NEJMoa030808","volume":"349","author":"JE Manson","year":"2003","unstructured":"Manson, J. E., Hsia, J., Johnson, K. C., Rossouw, J. E., Assaf, A. R., Lasser, N. L., et al. (2003). Women's health initiative investigators. Estrogen plus progestin and the risk of coronary heart disease. New England Journal of Medicine, 349, 523\u2013534.","journal-title":"New England Journal of Medicine"},{"key":"9105_CR3","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1001\/jama.1995.03520270033028","volume":"273","author":"The Writing Group for the PEPI Trial","year":"1995","unstructured":"The Writing Group for the PEPI Trial. (1995). Effects of estrogen or estrogen\/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen\/Progestin Interventions (PEPI) Trial. JAMA, 273, 199\u2013208.","journal-title":"JAMA"},{"key":"9105_CR4","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.jacc.2008.04.009","volume":"52","author":"J Suk Danik","year":"2008","unstructured":"Suk Danik, J., Rifai, N., Buring, J. E., & Ridker, P. M. (2008). Lipoprotein(a), hormone replacement therapy, and risk of future cardiovascular events. Journal of the American College of Cardiology, 52, 124\u2013131.","journal-title":"Journal of the American College of Cardiology"},{"key":"9105_CR5","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1056\/NEJM199703063361002","volume":"336","author":"KK Koh","year":"1997","unstructured":"Koh, K. K., Mincemoyer, R., Bui, M. N., Csako, G., Pucino, F., Guetta, V., et al. (1997). Effects of hormone-replacement therapy on fibrinolysis in postmenopausal women. New England Journal of Medicine, 336, 683\u2013690.","journal-title":"New England Journal of Medicine"},{"key":"9105_CR6","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1161\/01.CIR.91.7.1952","volume":"91","author":"OCE Gebara","year":"1995","unstructured":"Gebara, O. C. E., Mittleman, M. A., Sutherland, P., Lipinska, I., Matheney, T., Xu, P., et al. (1995). Association between increased estrogen status and increased fibrinolytic potential in the Framingham offspring study. Circulation, 91, 1952\u20131958.","journal-title":"Circulation"},{"key":"9105_CR7","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1001\/jama.280.7.605","volume":"280","author":"S Hulley","year":"1998","unstructured":"Hulley, S., Grady, D., Bush, T., Furberg, C., Herrington, D., Riggs, B., et al. (1998). Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. JAMA, 280, 605\u2013613.","journal-title":"JAMA"},{"key":"9105_CR8","first-page":"733","volume":"44","author":"N Kipshidze","year":"2004","unstructured":"Kipshidze, N., Dangas, G., Tsapenko, M., Moses, J., Leon, M. B., Kutryk, M., et al. (2004). Role of the endothelium in modulating neointimal formation: vasculoprotective approaches to attenuate restenosis after percutaneous coronary interventions. Journal of the American College of Cardiology, 44, 733\u2013739.","journal-title":"Journal of the American College of Cardiology"},{"key":"9105_CR9","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1016\/j.jacc.2008.03.017","volume":"51","author":"SH Choi","year":"2008","unstructured":"Choi, S. H., Prasad, A., & Tsimikas, S. (2008). The evolution of thienopyridine therapy: clopidogrel duration, diabetes, and drug-eluting stents. Journal of the American College of Cardiology, 51, 2228\u20132229.","journal-title":"Journal of the American College of Cardiology"},{"key":"9105_CR10","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1161\/01.CIR.95.7.1768","volume":"95","author":"K Krasinski","year":"1997","unstructured":"Krasinski, K., Spyridopoulos, I., Asahara, T., van der Zee, R., Isner, J. M., & Losordo, D. W. (1997). Estradiol accelerates functional endothelial recovery after arterial injury. Circulation, 95, 1768\u20131772.","journal-title":"Circulation"},{"key":"9105_CR11","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1159\/000025732","volume":"37","author":"P Concina","year":"2000","unstructured":"Concina, P., Sordello, S., Barbacanne, M. A., Elhage, R., Pieraggi, M. T., Fournial, G., et al. (2000). The mitogenic effect of 17beta-estradiol on in vitro endothelial cell proliferation and on in vivo reendothelialization are both dependent on vascular endothelial growth factor. Journal of Vascular Research, 37, 202\u2013208.","journal-title":"Journal of Vascular Research"},{"key":"9105_CR12","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1161\/01.CIR.97.22.2197","volume":"97","author":"G Nickenig","year":"1998","unstructured":"Nickenig, G., B\u00e4umer, A. T., Groh\u00e8, C., Kahlert, S., Strehlow, K., Rosenkranz, S., et al. (1998). Estrogen modulates AT1 receptor gene expression in vitro and in vivo. Circulation, 97, 2197\u20132201.","journal-title":"Circulation"},{"key":"9105_CR13","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1056\/NEJM199408253310801","volume":"331","author":"PW Serruys","year":"1994","unstructured":"Serruys, P. W., de Jaegere, P., Kiemeneij, F., Macaya, C., Rutsch, W., Heyndrickx, G., et al. (1994). A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group. New England Journal of Medicine, 331, 489\u2013495.","journal-title":"New England Journal of Medicine"},{"key":"9105_CR14","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1056\/NEJM199408253310802","volume":"331","author":"DL Fischman","year":"1994","unstructured":"Fischman, D. L., Leon, M. B., Baim, D. S., Schatz, R. A., Savage, M. P., Penn, I., et al. (1994). A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Study Investigators. New England Journal of Medicine, 331, 496\u2013501.","journal-title":"New England Journal of Medicine"},{"key":"9105_CR15","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1172\/JCI114081","volume":"83","author":"UC Garg","year":"1989","unstructured":"Garg, U. C., & Hassid, A. (1989). Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. Journal of Clinical Investigation, 83, 1774\u20131777.","journal-title":"Journal of Clinical Investigation"},{"key":"9105_CR16","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1016\/j.jacc.2005.11.077","volume":"47","author":"G Weisz","year":"2006","unstructured":"Weisz, G., Leon, M. B., Holmes, D. R., Kereiakes, D. J., Clark, M. R., Cohen, B. M., et al. (2006). Two-year outcomes after sirolimus-eluting stent implantation: Results from the Sirolimus-Eluting Stent in de Novo Native Coronary Lesions (SIRIUS) trial. Journal of the American College of Cardiology, 47, 1350\u20131355.","journal-title":"Journal of the American College of Cardiology"},{"key":"9105_CR17","doi-asserted-by":"crossref","first-page":"3876","DOI":"10.1161\/CIRCULATIONAHA.105.558601","volume":"112","author":"J Aoki","year":"2005","unstructured":"Aoki, J., Colombo, A., Dudek, D., Banning, A. P., Drzewiecki, J., Zmudka, K., et al. (2005). Peristent remodeling and neointimal suppression 2 years after polymer-based, paclitaxel-eluting stent implantation: insights from serial intravascular ultrasound analysis in the TAXUS II study. Circulation, 112, 3876\u20133883.","journal-title":"Circulation"},{"key":"9105_CR18","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.jacc.2006.03.042","volume":"48","author":"M Joner","year":"2006","unstructured":"Joner, M., Finn, A. V., Farb, A., Mont, E. K., Kolodgie, F. D., Ladich, E., et al. (2006). Pathology of drug eluting stents in humans: delayed healing and late thrombotic risk. Journal of the American College of Cardiology, 48, 193\u2013202.","journal-title":"Journal of the American College of Cardiology"},{"key":"9105_CR19","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.jacc.2007.04.030","volume":"50","author":"S Kaul","year":"2007","unstructured":"Kaul, S., Shah, P. K., & Diamond, G. A. (2007). As time goes by: current status and future directions in the controversy over stenting. Journal of the American College of Cardiology, 50, 128\u2013137.","journal-title":"Journal of the American College of Cardiology"},{"key":"9105_CR20","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1056\/NEJMoa067722","volume":"356","author":"B Lagerqvist","year":"2007","unstructured":"Lagerqvist, B., James, S. K., Stenestrand, U., Lindb\u00e4ck, J., Nilsson, T., & Wallentin, L. (2007). SCAAR Study Group. Long-term outcomes with drug-eluting stents versus bare-metal stents in Sweden. New England Journal of Medicine, 356, 1009\u20131119.","journal-title":"New England Journal of Medicine"},{"key":"9105_CR21","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1016\/j.jacc.2006.08.033","volume":"48","author":"D-W Park","year":"2006","unstructured":"Park, D.-W., Hong, M.-K., Mintz, G. S., Lee, C. W., Song, J.-M., Han, K.-H., et al. (2006). Two-year follow-up of the quantitative angiographic and volumetric intravascular ultrasound analysis after nonpolymeric paclitaxel-eluting stent implantation late \u201ccatch-up\u201d phenomenon from ASPECT study. Journal of the American College of Cardiology, 48, 2432\u20132439.","journal-title":"Journal of the American College of Cardiology"},{"key":"9105_CR22","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1161\/01.ATV.0000157579.52566.ee","volume":"25","author":"R Wessely","year":"2005","unstructured":"Wessely, R., Hausleiter, J., Michaelis, C., Jaschke, B., Vogeser, M., Milz, S., et al. (2005). Inhibition of neointima formation by a novel drug-eluting stent system that allows for dose-adjustable, multiple, and on-site stent coating. Arteriosclerosis, Thrombosis, and Vascular Biology, 25, 748\u2013753.","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biology"},{"key":"9105_CR23","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1021\/bi00511a014","volume":"20","author":"JC Beldekas","year":"1981","unstructured":"Beldekas, J. C., Smith, B., Gerstenfeld, L. C., Sonenshein, G. E., & Franzblau, C. (1981). Effects of 17 beta-estradiol on the biosynthesis of collagen in cultured bovine aortic smooth muscle cells. Biochemistry, 20, 2162\u20132167.","journal-title":"Biochemistry"},{"key":"9105_CR24","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1016\/S0735-1097(00)00940-2","volume":"36","author":"B Chandrasekar","year":"2000","unstructured":"Chandrasekar, B., & Tanguay, J.-F. (2000). Local delivery of 17-beta-estradiol decreases neointimal hyperplasia after coronary angioplasty in a porcine model. Journal of the American College of Cardiology, 36, 1972\u20131978.","journal-title":"Journal of the American College of Cardiology"},{"key":"9105_CR25","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1160\/TH04-12-0823","volume":"94","author":"B Chandrasekar","year":"2005","unstructured":"Chandrasekar, B., Sirois, M. G., Geoffroy, P., Lauzier, D., Nattel, S., & Tanguay, J.-F. (2005). Local delivery of 17-beta-estradiol improves reendothelialization and decrease inflammation after coronary stenting in porcine model. Thrombosis and Haemostasis, 94, 1042\u20131047.","journal-title":"Thrombosis and Haemostasis"},{"key":"9105_CR26","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1002\/ccd.10339","volume":"57","author":"G New","year":"2002","unstructured":"New, G., Moses, J. W., Roubin, G. S., Leon, M. B., Colombo, A., Iyer, S. S., et al. (2002). Estrogen-eluting, phosphorylcholine-coated stent implantation is associated with reduced neointimal formation but no delay in vascular repair in a porcine coronary model. Catheterization and Cardiovascular Interventions, 57, 266\u2013271.","journal-title":"Catheterization and Cardiovascular Interventions"},{"key":"9105_CR27","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1159\/000128603","volume":"45","author":"P Geraldes","year":"2008","unstructured":"Geraldes, P., Geoffroy, P., Cloutire, I., Sirois, M. G., & Tanguay, J.-F. (2008). Local delivery of 17-beta-estradiol modulates collagen content in coronary porcine arteries after PTCA and stent implantation. Journal of Vascular Research, 45, 503\u2013511.","journal-title":"Journal of Vascular Research"},{"key":"9105_CR28","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1016\/j.jacc.2004.01.023","volume":"43","author":"A Abizaid","year":"2004","unstructured":"Abizaid, A., Albertal, M., Costa, M. A., Abizaid, A. S., Staico, R., Feres, F., et al. (2004). First human experience with the 17-beta-estradiol-eluting stent: the Estrogen And Stents To Eliminate Restenosis (EASTER) trial. Journal of the American College of Cardiology, 43, 1118\u20131121.","journal-title":"Journal of the American College of Cardiology"},{"key":"9105_CR29","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1253\/circj.69.295","volume":"69","author":"N Shinozaki","year":"2005","unstructured":"Shinozaki, N., Yokoi, H., Iwabuchi, M., Nosaka, H., Kadota, K., Mitsudo, K., et al. (2005). Initial and follow-up results of the BiodivYsio phosphorylcholine coated stent for treatment of coronary artery disease. Circ J, 69, 295\u2013300.","journal-title":"Circ J"},{"key":"9105_CR30","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.amjcard.2005.04.040","volume":"96","author":"F Airoldi","year":"2005","unstructured":"Airoldi, F., Di Mario, C., Ribichini, F., Presbitero, P., Sganzerla, P., Ferrero, V., et al. (2005). 17-beta-estradiol eluting stent versus phosphorylcholine-coated stent for the treatment of native coronary artery disease. American Journal of Cardiology, 96, 664\u2013667.","journal-title":"American Journal of Cardiology"},{"key":"9105_CR31","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1002\/ccd.21210","volume":"70","author":"A Abizaid","year":"2007","unstructured":"Abizaid, A., Chaves, A. J., Leon, M. B., Hauptmann, K., Mehran, R., Lansky, A. J., et al. (2007). Randomized, double-blind, multicenter study of the polymer-based 17-beta estradiol-eluting stent for treatment of native coronary artery lesions: six-month results of the ETHOS I trial. Catheter Cardiovasc Interv, 70, 654\u2013660.","journal-title":"Catheter Cardiovasc Interv"},{"key":"9105_CR32","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1016\/j.jacc.2007.02.021","volume":"49","author":"T Adriaenssens","year":"2007","unstructured":"Adriaenssens, T., Mehilli, J., Wessely, R., Ndrepepa, G., Seyfarth, M., Wieczorek, A., et al. (2007). Does addition of estradiol improve the efficacy of a rapamycin-eluting stent? Results of the ISAR-PEACE randomized trial. J Am Coll Cardiol, 49, 1265\u20131271.","journal-title":"J Am Coll Cardiol"}],"container-title":["Journal of Cardiovascular Translational Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.springerlink.com\/index\/pdf\/10.1007\/s12265-009-9105-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,2,20]],"date-time":"2019-02-20T10:03:36Z","timestamp":1550657016000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12265-009-9105-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,5,19]]},"references-count":32,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,9]]}},"alternative-id":["9105"],"URL":"https:\/\/doi.org\/10.1007\/s12265-009-9105-x","relation":{},"ISSN":["1937-5387","1937-5395"],"issn-type":[{"value":"1937-5387","type":"print"},{"value":"1937-5395","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,5,19]]}}}